Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
fibrosis
Fierce Pharma
Big Pharma bets big on MASH with a new combo playbook
GSK, Roche and Novo jumped into MASH with a multibillion-dollar deal spree. Now, the phase 3 data have to deliver.
Ayla Ellison
Oct 17, 2025 9:30am
Roche launches liver fibrosis blood test for MASLD
May 7, 2025 10:30am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
Surrozen's Wnt mimetic antibody works in mice with lung fibrosis
Apr 4, 2024 4:30am
Ventoux drug slows fibrosis in mouse model of hand condition
Mar 12, 2024 11:00am
Akero soars as liver scarring improves in longer MASH trial
Mar 4, 2024 6:30am